HistoBlast: October 2020

A CRO Laboratory with a Global Presence
For Expertise Where You Need It

We are expanding our presence worldwide to better serve our clients and to support global clinical trials. All our locations are dedicated to quality science and strong regulatory compliance. Our platforms and systems are standardized globally and follow well-defined processes to safeguard your data. In addition to our commitment to superior sample management, you can count on our local scientific teams at every site for guidance on assay development and sample processing.

With a comprehensive suite of innovative services across our immune monitoring, proteomic, histopathology, and genomic platforms, Caprion-HistoGeneX is the ideal partner for your global clinical trials.

59dfcda4 1dec 48d8 9e05 e44726b7b378


5d8b7ea8 07ea 474c abfd d0b2eee645a2

Now Open in China!
Our New Site in Jining

 

Our flow cytometry (BD FACSLyricTM - 12-color analysis) and immunohistochemistry (IHC) services are now up and running in Jining, China. The Meso Scale Discovery (MSD) platform is part of the next phase of our laboratory expansion which is currently underway.

The site’s CAP accreditation is also underway, and the following certificates have been obtained: Human Genetics Resources Administration of China (HGRAC), biosafety level 2 certification, and import permits. Our import permits allow us to receive the necessary reagents and specimens for assay qualification and transfer in a timely manner.

Contact us for more information about our Chinese site.


5d8b7ea8 07ea 474c abfd d0b2eee645a2

North American Facilities

  • Montreal (Canada)
  • Naperville (USA)
  • Fremont (USA)
  • Carlsbad (USA)

 

Headquartered in Montreal, Caprion-HistoGeneX has grown both organically and through acquisitions. Recent acquisitions of laboratories in the San Francisco area and Southern California technology district have allowed us to strategically expand our North American footprint. Altogether, our North American facilities provide our comprehensive set of services – immune monitoring, proteomics, histopathology, and genomics.

We can now feature many new technologies such as mass cytometry (CyTOF), and others are coming soon. Mass cytometry represents a fundamental advancement in single cell analysis and greatly increases the depth of our immune monitoring capabilities.

Contact us for more information about our North American sites.


b48b277a eb33 4ba3 becb 6686481b5ff4

European Facilities

  • Antwerp (Belgium)
  • Gosselies (Belgium)
  • Guildford (UK)

 

Our European sites allow for a combined and harmonious access of flow cytometry, immunohistochemistry, and genomic services.

The RareCyte® platform allows us to easily identify circulating tumor cells (CTCs) in peripheral blood through fluorescent staining and perform a genomic analysis on single cells. Given the reproducible automated staining and analysing of this platform, it is commonly used in large-scale clinical trials.

Contact us for more information about our European sites.


49857f15 f51b 478f af12 bf8d3a68cbb4

Caprion-HistoGeneX in Australia

We are currently expanding our flow cytometry services to better serve our Asian/Pacific clients with a new site in Australia.


Contact Us

Caprion - HistoGeneX is a leading provider of specialized precision medicine services to the biopharmaceutical industry including flow and mass cytometry immune monitoring, quantitative mass spectrometry, molecular profiling, as well as quantitative immunohistochemistry. Leveraging its integrated platforms, Caprion-HistoGeneX supports the entire drug development cycle, from discovery to clinical trials. The company operates globally with laboratories located in Canada, USA, Belgium, UK, Australia, and China.

For more information: www.caprion.com and www.histogenex.com.

light linkedin 96 light link 96 This email address is being protected from spambots. You need JavaScript enabled to view it.

FAQs

Where can I find previous HistoBlasts? Find them here.

For a conversation about our laboratory, please contact your project manager, business development executive, or This email address is being protected from spambots. You need JavaScript enabled to view it..

You can send in additional questions This email address is being protected from spambots. You need JavaScript enabled to view it..